Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris

April 10, 2017 at 3:30 pm

Emerging Infectious Diseases February 2017 V.23 N.2

Dispatch

Leighann Sherry, Gordon Ramage, Ryan Kean, Andrew Borman, Elizabeth M. Johnson, Malcolm D. Richardson, and Riina Rautemaa-RichardsonComments to Author

University of Glasgow, Glasgow, Scotland, UK (L. Sherry, G. Ramage, R. Kean); Public Health England, Bristol, UK (A. Borman, E.M. Johnson); The University of Manchester, Manchester, UK (M.D. Richardson, R. Rautemaa-Richardson); University Hospital of South Manchester, Manchester (M.D. Richardson, R. Rautemaa-Richardson)

The emerging multidrug-resistant yeast pathogen Candida auris has attracted considerable attention as a source of healthcare–associated infections.

We report that this highly virulent yeast has the capacity to form antifungal resistant biofilms sensitive to the disinfectant chlorhexidine in vitro.

PDF

https://wwwnc.cdc.gov/eid/article/23/2/pdfs/16-1320.pdf

Advertisements

Entry filed under: Antimicoticos, Biología Molecular, Epidemiología, Health Care-Associated Infections, Infecciones emergentes, Infecciones micoticas, Infecciones nosocomiales, Metodos diagnosticos, REPORTS, Sepsis, Update.

2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update


Calendar

April 2017
M T W T F S S
« Mar   May »
 12
3456789
10111213141516
17181920212223
24252627282930

Most Recent Posts


%d bloggers like this: